<DOC>
	<DOC>NCT01249846</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and the safety of Chlorhexidine Gluconate Chip (PerioChip®) in frequent treatment versus routine treatment in therapy of adult chronic periodontitis.</brief_summary>
	<brief_title>The Efficacy and Safety of 2.5 mg Chlorhexidine Gluconate Chip (PerioChip®) in Frequent Treatment Versus Routine Treatment in Therapy of Adult Chronic Periodontitis</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>1. Signed and dated Informed Consent Form. 2. Good general health. 3. Male or female patients aged &gt;21 years old. 4. Availability for the 25 week duration of the study. 5. Chronic periodontal disease on natural teeth 6. Females of childbearing potential must be nonpregnant and nonlactating at entry and agree to use an adequate method of birth control during the study. 1. Oral health or factor that may influence the outcome of the study. 2. History of allergy to Chlorhexidine . 3. Patient uses Chlorhexidine oral rinses/mouthwashes on a regular basis. 4. Patients treated with medications that may influence the outcome of the study. 5. Presence of any of the following conditions: Type 1 diabetes, uncontrolled type II diabetes, major recurrent aphtae stomatitis, abscesses and related oral pathologies. 6. The presence of any medical or psychiatric condition or any other condition that, in the opinion of the Investigator, could affect the successful participation of the patient in the study. 7. Patient participates in any other clinical study 30 days prior to the start of the study and throughout the study duration.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>